Cargando…
Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis
BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exce...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508680/ https://www.ncbi.nlm.nih.gov/pubmed/32995454 http://dx.doi.org/10.1016/j.gore.2020.100641 |
_version_ | 1783585461312159744 |
---|---|
author | Kahn, Ryan Matthew Gandhi, Shreena Kamlesh Mvula, Mwamba Rebecca Li, Xuan Frey, Melissa K. |
author_facet | Kahn, Ryan Matthew Gandhi, Shreena Kamlesh Mvula, Mwamba Rebecca Li, Xuan Frey, Melissa K. |
author_sort | Kahn, Ryan Matthew |
collection | PubMed |
description | BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exceedingly rare with minimal reported cases in literature. CASE: This is a rare case of highly aggressive EOC in a previously healthy 32-year-old woman with evidence of brain, bone, and vertebral metastasis at the time of initial diagnosis. This is the first reported case of EOC with spread to Meckel’s cave with symptoms consistent with trigeminal nerve disruption. The disease rapidly progressed through radiation and front-line chemotherapy. CONCLUSION: This report highlights the first reported case of EOC with invasion of Meckel’s cave—present at time of diagnosis. Consistent with most cases in the literature of brain metastasis in the setting of EOC, our patient had a highly aggressive tumor associated with a poor prognosis. With better primary management of EOC, along with increased overall survival in EOC patients following spread to the brain secondary to multimodal therapies, we can continue to expect increasing numbers of brain metastasis with uncommon sites of recurrence. |
format | Online Article Text |
id | pubmed-7508680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75086802020-09-28 Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis Kahn, Ryan Matthew Gandhi, Shreena Kamlesh Mvula, Mwamba Rebecca Li, Xuan Frey, Melissa K. Gynecol Oncol Rep Case Report BACKGROUND: Brain metastasis occurs in 1–2.5% of epithelial ovarian cancer (EOC) cases and carries a poor prognosis. Typically, brain metastases arise 2–3 years following the primary diagnosis of EOC. Malignant spread to the brain discovered at the time of initial ovarian cancer presentation is exceedingly rare with minimal reported cases in literature. CASE: This is a rare case of highly aggressive EOC in a previously healthy 32-year-old woman with evidence of brain, bone, and vertebral metastasis at the time of initial diagnosis. This is the first reported case of EOC with spread to Meckel’s cave with symptoms consistent with trigeminal nerve disruption. The disease rapidly progressed through radiation and front-line chemotherapy. CONCLUSION: This report highlights the first reported case of EOC with invasion of Meckel’s cave—present at time of diagnosis. Consistent with most cases in the literature of brain metastasis in the setting of EOC, our patient had a highly aggressive tumor associated with a poor prognosis. With better primary management of EOC, along with increased overall survival in EOC patients following spread to the brain secondary to multimodal therapies, we can continue to expect increasing numbers of brain metastasis with uncommon sites of recurrence. Elsevier 2020-09-11 /pmc/articles/PMC7508680/ /pubmed/32995454 http://dx.doi.org/10.1016/j.gore.2020.100641 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kahn, Ryan Matthew Gandhi, Shreena Kamlesh Mvula, Mwamba Rebecca Li, Xuan Frey, Melissa K. Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title | Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title_full | Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title_fullStr | Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title_full_unstemmed | Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title_short | Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis |
title_sort | metastatic epithelial ovarian cancer to meckel’s cave with leptomeningeal spread at time of diagnosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508680/ https://www.ncbi.nlm.nih.gov/pubmed/32995454 http://dx.doi.org/10.1016/j.gore.2020.100641 |
work_keys_str_mv | AT kahnryanmatthew metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis AT gandhishreenakamlesh metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis AT mvulamwambarebecca metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis AT lixuan metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis AT freymelissak metastaticepithelialovariancancertomeckelscavewithleptomeningealspreadattimeofdiagnosis |